Early efficacy of taxotere and cisplatin chemo-radiotherapy for advanced cervical cancer

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 2, 2012, Pages 617-619

  Ke, Qing Hua ^a   Zhou, Shi Qiong ^a   Du, Wei ^a   Lei, Yong ^a   Huang, Min ^a   Luo, Fei ^a   Yang, Ji Yuan ^a  

^a Department of Chemoradiotherapy   (China)

Author keywords

Cervical cancer; Chemoradiotherapy; Taxotere and cisplatin

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DOCETAXEL; TAXOID;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER GRADING; CHEMORADIOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; METASTASIS; MIDDLE AGED; PATHOLOGY; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; REMISSION; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX TUMOR;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRACHYTHERAPY; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; CISPLATIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM GRADING; PROGNOSIS; REMISSION INDUCTION; TAXOIDS; UTERINE CERVICAL NEOPLASMS;

EID: 84866469905     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.2.617     Document Type: Article

References (16)

1. Bai XK, Zhao Z (2001). The clinic investigation of the effectiveness of medicine MA on the survival condition of cancer patients in chemotherapy period. Shanxi Oncol Med, 9, 161-2.
2. Dubay RA, Rose PG, O'Malley DM, et al (2004). Evaluation of concurrent and adjuvant carboplatin with radiation therapy for locally advanced cervical cancer. Gynecol Oncol, 94, 121-4.
3. Dueñas-González A, Zarbá JJ, Patel F, et al (2011). Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix. J Clin Oncol, 29, 1678-85.
4. Eifel PJ, Winter K, Morris M, et al (2004). Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high- risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. J Clin Oncol, 22, 872-80.
5. Green JA, Kirwan JM, Tierney JF, et al (2001). Survival and recurrence after concom itant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet, 358, 781-6.
6. Higgins RV, Naumann WR, Hall JB, et al (2003). Concurrent carboplatin with pelvic radiation therapy in the primary treatment of cervix cancer. Gynecol Oncol, 89, 499-503.
7. Lorvidhaya V, Chitapanarux I, Sangruchi S, et al (2003). Concurrent mitomycin C, 5-fluorouracil, and radiotherapy in the treatment of locally advanced carcinoma of the cervical: a randomized trial. Int J Radiat Oncol Biol Phys, 55, 1226-32.
8. Lu P, Liang QD, Zheng QQ (2003). Influence of clinical and pathologic parameters on prognosis of cervical carcinoma in China. Chinese-German J Clin Oncol, 2, 163-5.
9. Morris M, Eifel PJ, Lu J, et al (1999). Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high- risk cervical cancer. N Engl J Med, 340, 1137-43.
10. Peters WA, Liu PY, Barrett RJ, et al (2000). Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervical. J Clin Oncol, 18, 1606-13.
11. Pignata S, Frezza P, Tramontana S, et al (2000). Phase ? study with weekly cisplatin-paclitaxel and concurrent radiotherapy in patients with carcinoma of the cervix uteri. Ann Oncol, 11, 455-9.
12. Rose PG, Ali S, Watkins E, et al (2007). Long-term follow-up of a randomized trial comparing concurrent single agent cisplatin, cisplatin-based combination chemotherapy, or hydroxyurea during pelvic irradiation for locally advanced cervical cancer: a Gynecologic Oncology Group Study. J Clin Oncol, 25, 2804-10.
13. Rose PG, Bundy BN, Watkins EB, et al (1999). Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med, 340, 1144-53.
14. Sun Y, Zhou JC (2002). 4 Edition. Beijing: People's Medical Publishing House. Manual of medical oncology, 106-418.
15. Thomas GM (1999). Improved treatment for cervical cancer- concurrent chemotherapy and radiotherapy. N Engl J Med, 340, 1198-200.
16. Wang HQ (2002). Shenyang: Lianing Sience and Tchnology Publishing House. Malignant tumor chemotherapy regimens norms, 16.